Last reviewed · How we verify
infections
Approved treatments
- Xolremdi · X4 Pharms
Xolremdi blocks the CXC Chemokine Receptor 4 to treat WHIM syndrome.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- infections patent landscape — cliff calendar, originator estates, attackable patents
- infections treatment landscape brief
- infections treatment updates RSS
Frequently asked questions about infections
What drugs treat infections?
Tracked treatments include Xolremdi.
What is the treatment for infections?
Standard treatment for infections includes Xolremdi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: infections patent cliff · infections CI report
- Treatment: Xolremdi · X4 Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing